Last mentioned: 3d ago
Global Market Reaction
Industry analysts note the deal as a major consolidation in the GLP-1 and telehealth sectors.
Payout Details Emerge
Former CCO Joe Harris confirms a payout exceeding $1 million, highlighting the impact on staff wealth.
Acquisition Announced
Hims & Hers officially announces the $1.6 billion buyout of Sydney-based Eucalyptus.
The FDA has issued a formal warning letter to Novo Nordisk for failing to properly report serious adverse events, including deaths and strokes, related to its GLP-1 medications. This regulatory escalation coincides with a significant market valuation decline and intensifying competition from compounding pharmacies.
US telehealth leader Hims & Hers has finalized a $1.6 billion acquisition of Australian digital health startup Eucalyptus, marking a major expansion into the Asia-Pacific market. The deal, driven by the explosive growth of GLP-1 weight-loss treatments, creates over 100 employee millionaires and solidifies Hims & Hers' position as a global powerhouse in direct-to-consumer healthcare.